Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nephrogenic diabetes insipidus caused by a novel missense variant (p.S127Y) in the AVPR2 gene. | Clin Pediatr Endocrinol | 2021 | 33867673 | PubTator, text mining | PubMed |
| A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease. | Cell Metab | 2021 | 33852874 | PubTator, text mining | PubMed |
| Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma. | Exp Ther Med | 2021 | 33850538 | PubTator, text mining | PubMed |
| Epithelial proliferation and cell cycle dysregulation in kidney injury and disease. | Kidney Int | 2021 | 33831367 | PubTator, text mining | PubMed |
| The evolving complexity of the collecting duct renin-angiotensin system in hypertension. | Nat Rev Nephrol | 2021 | 33824491 | PubTator, text mining | PubMed |
| Biodistribution and Pharmacokinectics of Liposomes and Exosomes in a Mouse Model of Sepsis. | Pharmaceutics | 2021 | 33809966 | PubTator, text mining | PubMed |
| Ethnobotanical Research and Compilation of the Medicinal Uses in Spain and the Active Principles of Chiliadenus glutinosus (L.) Fourr. for the Scientific Validation of Its Therapeutic Properties. | Plants (Basel) | 2021 | 33808620 | PubTator, text mining | PubMed |
| The Effect of Vasopressin Antagonists on Maternal-Separation-Induced Ultrasonic Vocalization and Stress-Hormone Level Increase during the Early Postnatal Period. | Brain Sci | 2021 | 33808441 | PubTator, text mining | PubMed |
| Crosstalk between Renal and Vascular Calcium Signaling: The Link between Nephrolithiasis and Vascular Calcification. | Int J Mol Sci | 2021 | 33808324 | PubTator, text mining | PubMed |
| Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis. | Biomedicines | 2021 | 33804115 | PubTator, text mining | PubMed |
| Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology. | Life (Basel) | 2021 | 33804034 | PubTator, text mining | PubMed |
| Pharmacologic management of nocturnal polyuria: a contemporary assessment of efficacy, safety, and progress toward individualized treatment. | Ther Adv Urol | 2021 | 33796148 | PubTator, text mining | PubMed |
| Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management. | Cureus | 2021 | 33786230 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals putatively novel associations in retinopathies and drusen formation. | Eur J Hum Genet | 2021 | 33776059 | PubTator, text mining | PubMed |
| Maternal selenium deficiency in mice promotes sex-specific changes to urine flow and renal expression of mitochondrial proteins in adult offspring. | Physiol Rep | 2021 | 33769708 | PubTator, text mining | PubMed |
| Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. | Curr Opin Endocr Metab Res | 2021 | 33748531 | PubTator, text mining | PubMed |
| Molecular basis of ligand recognition and activation of human V2 vasopressin receptor. | Cell Res | 2021 | 33742150 | Swiss-Prot, curated | PubMed |
| Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients. | Kidney Int Rep | 2021 | 33732999 | PubTator, text mining | PubMed |
| An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus. | JCI Insight | 2021 | 33724959 | PubTator, text mining | PubMed |
| β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells. | Med Oncol | 2021 | 33721131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=42